Metformin Hydrochloride Milpharm (Metformin Hydrochloride)

Metformin Hydrochloride lowers blood glucose primarily by inhibiting mitochondrial complex I, which reduces hepatic gluconeogenesis. It also enhances peripheral insulin sensitivity, promoting glucose uptake in skeletal muscle and adipose tissue, and modestly increases glucose utilization in the gastrointestinal tract, all without stimulating insulin secretion.

The appropriate dose of Metformin Hydrochloride is determined by the prescribing clinician based on the individual patient's medical condition, renal function, and response to therapy. Dosage may be started low and titrated upward to achieve optimal glycaemic control while minimizing side effects.

Safety of Metformin Hydrochloride in pregnancy or while breastfeeding should be evaluated by a healthcare professional. Current guidelines suggest it may be used during pregnancy when the benefits outweigh potential risks, but it is generally avoided unless specifically indicated. Breastfeeding mothers should consult their physician before use.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide. After submission, the sales team will verify trade or institutional credentials, then provide pricing, availability, shipping details (including any cold‑chain requirements), and assist with import documentation.

Metformin Hydrochloride belongs to the biguanide class and is often first‑line therapy for type 2 diabetes due to its efficacy, low risk of hypoglycaemia, and favourable impact on weight. Compared with sulfonylureas, it does not stimulate insulin release, and unlike insulin, it is administered orally. It is frequently combined with other agents when monotherapy is insufficient.

Metformin Hydrochloride tablets should be stored at room temperature, below 25 °C, in the original packaging to protect from moisture and light. Keep the container tightly closed and out of reach of children. Do not store in humid or excessively hot environments, as this may affect tablet integrity.

Metformin Hydrochloride is taken orally, usually with meals to reduce gastrointestinal discomfort. Tablets should be swallowed whole with a full glass of water. The exact dosing schedule and frequency are prescribed by the treating physician based on individual therapeutic goals and tolerability.

The most serious risk is lactic acidosis, a rare but potentially fatal condition that can occur in patients with severe renal impairment, hepatic disease, or excessive alcohol intake. Other serious concerns include vitamin B12 deficiency with long‑term use and rare severe skin reactions such as Stevens‑Johnson syndrome.

Metformin Hydrochloride is contraindicated in patients with severe renal impairment (eGFR < 30 mL/min/1.73 m²), acute or chronic metabolic acidosis, including diabetic ketoacidosis, and in those with known hypersensitivity to metformin. Caution is also advised for individuals with significant hepatic disease, heart failure, or a history of lactic acidosis.